{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-037533","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.252569+00:00","generated_at":"2026-05-26T02:29:35.871896+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LifeStance appoints Dave Bourdon as CEO; Ken Burdick becomes Executive Chairman; Ryan McGroarty named CFO","bullets":["Dave Bourdon, CFO since 2022, becomes CEO effective March 3, 2025; Ryan McGroarty appointed CFO effective March 17, 2025.","Ken Burdick retires as CEO and becomes Executive Chairman, continuing on the Board.","Bourdon's new annual base salary is $700,000; target bonus 100% of salary for 2025.","McGroarty receives $550,000 base salary, $570,000 signing bonus, and $5M target equity award (RSUs and PSUs).","Both appointments follow nine consecutive quarters of meeting or exceeding financial expectations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-037533","json":"https://secwatch.observer/filing/0001193125-25-037533.json","markdown":"https://secwatch.observer/filing/0001193125-25-037533.md","text":"https://secwatch.observer/filing/0001193125-25-037533.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/0001193125-25-037533-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/d911509d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T02:29:35.871896+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"182b8210e7","claim":"Kenneth Burdick retired as Executive Chairman at LifeStance Health Group, Inc..","evidence_excerpt":"Mr. Bourdon will succeed Kenneth Burdick, who has served as the Company’s Chief Executive Officer since 2022 and who is retiring from his position, effective as of the CEO Start Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/0001193125-25-037533-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"},{"claim_id":"33892eac97","claim":"David Bourdon changed role as Chief Executive Officer at LifeStance Health Group, Inc..","evidence_excerpt":"promoted David Bourdon to serve as the Company’s Chief Executive Officer effective as of March 3, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/0001193125-25-037533-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"6282df61ba","claim":"Ryan McGroarty was appointed as Chief Financial Officer and Treasurer at LifeStance Health Group, Inc..","evidence_excerpt":"the Board of Directors also appointed Ryan McGroarty as the Company’s Chief Financial Officer and Treasurer, effective as of March 17, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/0001193125-25-037533-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}